GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (BSP:Q1UE34) » Definitions » Cyclically Adjusted PS Ratio

Quest Diagnostics (BSP:Q1UE34) Cyclically Adjusted PS Ratio : 1.75 (As of Jun. 06, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Quest Diagnostics Cyclically Adjusted PS Ratio?

As of today (2024-06-06), Quest Diagnostics's current share price is R$328.82. Quest Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was R$188.36. Quest Diagnostics's Cyclically Adjusted PS Ratio for today is 1.75.

The historical rank and industry rank for Quest Diagnostics's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:Q1UE34' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.26   Med: 1.9   Max: 2.78
Current: 1.87

During the past years, Quest Diagnostics's highest Cyclically Adjusted PS Ratio was 2.78. The lowest was 1.26. And the median was 1.90.

BSP:Q1UE34's Cyclically Adjusted PS Ratio is ranked better than
61.07% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.5 vs BSP:Q1UE34: 1.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Quest Diagnostics's adjusted revenue per share data for the three months ended in Mar. 2024 was R$52.599. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$188.36 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Quest Diagnostics Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Quest Diagnostics's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Cyclically Adjusted PS Ratio Chart

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.99 2.11 2.73 2.24 1.85

Quest Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.97 1.92 1.64 1.85 1.75

Competitive Comparison of Quest Diagnostics's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Quest Diagnostics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Cyclically Adjusted PS Ratio falls into.



Quest Diagnostics Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Quest Diagnostics's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=328.82/188.36
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Quest Diagnostics's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=52.599/131.7762*131.7762
=52.599

Current CPI (Mar. 2024) = 131.7762.

Quest Diagnostics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 14.665 100.560 19.217
201409 15.350 100.428 20.141
201412 16.806 99.070 22.354
201503 19.784 99.621 26.170
201506 20.655 100.684 27.033
201509 25.304 100.392 33.215
201512 24.743 99.792 32.673
201603 23.921 100.470 31.375
201606 22.975 101.688 29.773
201609 21.593 101.861 27.935
201612 18.821 101.863 24.348
201703 20.151 102.862 25.815
201706 21.938 103.349 27.972
201709 20.764 104.136 26.275
201712 21.947 104.011 27.806
201803 22.222 105.290 27.812
201806 26.031 106.317 32.265
201809 27.918 106.507 34.542
201812 25.689 105.998 31.936
201903 26.701 107.251 32.807
201906 27.684 108.070 33.757
201909 29.408 108.329 35.773
201912 29.063 108.420 35.324
202003 32.973 108.902 39.899
202006 34.850 108.767 42.222
202009 54.907 109.815 65.888
202012 56.781 109.897 68.086
202103 56.768 111.754 66.938
202106 50.483 114.631 58.033
202109 58.576 115.734 66.695
202112 62.068 117.630 69.533
202203 53.692 121.301 58.329
202206 52.025 125.017 54.838
202209 55.236 125.227 58.125
202212 53.207 125.222 55.992
202303 53.722 127.348 55.590
202306 49.772 128.729 50.950
202309 49.712 129.860 50.446
202312 50.048 129.419 50.959
202403 52.599 131.776 52.599

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Quest Diagnostics  (BSP:Q1UE34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Quest Diagnostics Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (BSP:Q1UE34) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (BSP:Q1UE34) Headlines

No Headlines